ECM
LONA

EMC Capital Management’s LeonaBio Inc LONA Stock Holding History

EMC Capital Management’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,649
Closed -$346K – 118
2021
Q3 		$346K Buy
2,649
+479
+22% +$48.8K 0.19% 83
2021
Q2 		$222K Buy
+2,170
New +$379K 0.13% 96

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

EMC Capital Management's LONA Position: Q4 2021 in Review

EMC Capital Management sold out of LeonaBio Inc (LONA) in Q4 2021, closing a stake of 2,649 shares — an estimated $346K sold.

EMC Capital Management first reported a position in LONA in Q2 2021 and held it in 2 quarters. The position peaked at $346K in Q3 2021. 103 funds tracked by Wall St. Rank hold LONA as of Q4 2021.

  • EMC Capital Management reported no remaining LeonaBio Inc position as of Q4 2021 after selling out during the quarter.
  • EMC Capital Management sold 2,649 LeonaBio Inc shares in Q4 2021, an estimated $346K.
  • EMC Capital Management first reported a position in LeonaBio Inc in Q2 2021 and held it in 2 quarters.
  • EMC Capital Management's LeonaBio Inc position peaked at $346K in Q3 2021.
  • 103 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2021.

Based on EMC Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.